Effects of Schedule I drug laws on neuroscience research and treatment innovation. (2013)
Attributed to:
Psilocybin as a treatment for major depression
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/nrn3530
PubMed Identifier: 23756634
Publication URI: http://europepmc.org/abstract/MED/23756634
Type: Journal Article/Review
Volume: 14
Parent Publication: Nature reviews. Neuroscience
Issue: 8
ISSN: 1471-003X